| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Chief Commercial Officer
1 company
Jeffrey Dierks last filed a Form 4 in March 2025, as Chief Commercial Officer at HRMY. From June 2021 to March 2025, the filings on record show 0 open-market purchases and 23 sales. Jeffrey Dierks's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Jeffrey Dierks a middling insider score of 62/100, based on 28 past trades. Over a 12-month horizon, 53.6% of those trades were profitable, with an average 12-month return of -1.5%.
Shares as reported in the last Form 4 for each company; the most recent is from March 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2021 | HRMY Harmony Biosciences Holdings, Inc. | Chief Commercial Officer | Sale+OE | 10,000 | $33.61 | $336,125.20 | - | -0.5% | +32.4% | |
| Aug 27, 2021 | HRMY Harmony Biosciences Holdings, Inc. | Chief Commercial Officer | Sale+OE | 5,000 | $35.13 | $175,625.12 | - | +6.5% | +35.0% | |
| Jun 15, 2021 | HRMY Harmony Biosciences Holdings, Inc. | Chief Commercial Officer | Sale+OE | 15,000 | $31.32 | $469,806.00 | - | +13.9% | +40.6% |